Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-03-05

Clinical Trial Update: A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic Pain [Phase 3]

View source ↗

Summary

Phase 3 trial of fixed combination acetaminophen/naproxen for orthodontic pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetaminophen/naproxen fixed combination

Snippet

Sponsor: Johnson & Johnson Consumer Inc. (J&JCI) | Conditions: Orthodontic Pain | Phase 3 | Status: WITHDRAWN